Roivant Sciences Ltd.
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Roivant Sciences Ltd. generated cash of -$765,268,000, which is more than the previous year. Cash used in financing activities reached the amount of $419,364,000 last year. Net change in cash is therefore $4,858,335,000.

Cash Flow

Roivant Sciences Ltd. (NASDAQ:ROIVW): Cash Flow
2020 -761.83M 1.69B 217.16M
2021 -552.13M -31.70M 456.26M
2023 -843.39M -44.26M 499.46M
2024 -765.26M 5.20B 419.36M

ROIVW Cash Flow Statement (2019 – 2023)

2023 2022 2021 2019
Cash at beginning of period
1.69B2.07B2.26B849.55M
Operating activities
Net income
4.23B-1.11B-900.23M-519.39M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
22.03M18.85M00
Stock-based compensation expense
199.62M217.78M84.95M0
Deferred income tax benefit 199.62M217.78M84.95M0
Changes in operating assets and liabilities:
Accounts receivable, net
0000
Inventories
0000
Accounts payable
22.68M4.35M3.75M6.59M
Cash generated by operating activities
-765.26M-843.39M-552.13M-761.83M
Investing activities
Purchases Of Investments
00-28.25M-68.37M
Investments In Property Plant And Equipment
-1.38M-12.69M-5.80M-4.91M
Acquisitions Net
-36.98M107.85M01.77B
Cash generated by investing activities
5.20B-44.26M-31.70M1.69B
Financing activities
Common Stock Issued
438.55M379.70M455.75M1.35B
Payments for dividends
-6M000
Repurchases of common stock
00-113K-1.18B
Repayments of term debt
-30.70M129.75M0-32.06M
Cash used in financing activities
419.36M499.46M456.26M217.16M
Net Change In Cash
4.85B-381.91M-127.57M0
Cash at end of period
6.55B1.69B2.14B2.18B
Data sourceData source